Your browser doesn't support javascript.
loading
Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors.
Kalan, Sampada; Amat, Ramon; Schachter, Miriam Merzel; Kwiatkowski, Nicholas; Abraham, Brian J; Liang, Yanke; Zhang, Tinghu; Olson, Calla M; Larochelle, Stéphane; Young, Richard A; Gray, Nathanael S; Fisher, Robert P.
Afiliación
  • Kalan S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Amat R; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Schachter MM; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Kwiatkowski N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Abraham BJ; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
  • Liang Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Olson CM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Larochelle S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Young RA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, MA 02142, USA.
  • Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Fisher RP; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: robert.fisher@mssm.edu.
Cell Rep ; 21(2): 467-481, 2017 Oct 10.
Article en En | MEDLINE | ID: mdl-29020632
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenilendiaminas / Pirimidinas / Proteína p53 Supresora de Tumor / Quinasas Ciclina-Dependientes / Inhibidores de Proteínas Quinasas / Antineoplásicos Límite: Humans Idioma: En Revista: Cell Rep Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenilendiaminas / Pirimidinas / Proteína p53 Supresora de Tumor / Quinasas Ciclina-Dependientes / Inhibidores de Proteínas Quinasas / Antineoplásicos Límite: Humans Idioma: En Revista: Cell Rep Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos